Van Veelen and De Groot in 2009 confirm the above findings, as CEA, although a non-specific biological indicator in the diagnosis of MTC, can be associated preoperatively with tumor size, MTC recurrence, disease prognosis and presence of lymph node metastases. The gene discussed is CEACAM7; the disease is neoplasm.